白雲山(600332.SH):醫藥公司擬通過增資擴股 引入戰略合作伙伴及對管理層及核心骨幹員工持股
格隆匯 8 月 6日丨白雲山(600332.SH)公佈,為滿足醫藥公司進一步做大做強業務規模、興建醫藥物流設施、延伸醫藥供應鏈等需要,進一步提高醫藥公司的市場滲透能力,廣州醫藥股份有限公司(“醫藥公司”)擬通過增資擴股引入戰略合作伙伴及對管理層及核心骨幹員工持股。增資完成後,醫藥公司的總股本將由222,700萬股增加至不多於260,946.99萬股。
此次增資擴股擬通過增量發行新股方式引入普通投資者、戰略投資者,同時引入管理層及核心骨幹員工持股,使醫藥公司變為由原股東白雲山、ALLIANCE BMP LIMITED與投資方共同持股的股份有限公司。醫藥公司擬向普通投資者增發不多於14342.62萬股股份,增資金額不高於人民幣3.6億元;向戰略投資者增發不多於19920.31萬股股份,增資金額不高於人民幣5億元;向管理層及核心骨幹員工持股平台增發不多於3984.06萬股股份,增資金額不高於人民幣1億元,最終增發股份數量根據廣州產權交易所公開徵集的投資方實際增資的情況並經醫藥公司董事會及股東大會審議後確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.